NEURODEGENERATIVE DISEASE TREATMENT MARKET ANALYSIS

Regional Analysis

Global Neurodegenerative Disease Market: Regional Insights

Based on geography, the global neurodegenerative disease market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Among regions, North America is expected to gain highest share in the market during the forecast period owing to the increasing burden of neurodegenerative diseases, increasing public awareness, and increase in demand for safe and effective treatments in the region. For instance, according to the Alzheimer's Association, more than 6.5 million people (aged 65 and older) in the United States were living with Alzheimer's dementia in 2022, and this number is expected to reach around 12.7 million by 2050.

Europe and Asia Pacific are also expected to witness robust growth in the global neurodegenerative disease market due to the rise in prevalence of neurodegenerative diseases, increase in demand for novel therapeutics, and rise in public awareness in these regions. For instance, according to the Parkinson’s Europe, around 1.2 million people are living with Parkinson's disease (PD) in Europe and this number is expected to double by 2030. Parkinson's requires a personalised approach to treatment and care.